Abstract:Objective Glucocorticoid (GC) is the principal therapeutic drug in the treatment of idiopathic nephrotic syndrome (INS), and the response to GC treatment is an important indicator for the outcome of INS children. Children with GC-resistant INS are usually incompletely or non responseive to GC, and may herald the progression to end-stage renal failure. However, the detailed mechanism for why some INS children respond to GC and others do not, have still not been clearly elucidated. It is well known that GC action is mediated by the GC receptor (GR), a ligand-dependent transcription factor that belongs to the super-family of nuclear receptors. Two human GR isoforms termed GR α and GR β have been described. Recent studies demonstrated that the β-isoform of GR (GR β) is a potential endogenous inhibitor of the GC action in humans. So far, no research papers have involved in the relationship between the levels of two GR isoforms, GR α and GR β, expression in INS children and the response to GC in INS children. The aim of the present study was to determine the levels of GR α and GR β in INS children with the variable response to the GC treatment. Methods Twenty patients aged 4～13 years with INS were classified as GC-sensitive INS (8 patients) or GC-resistant INS (12 patients), according to their response to an eight-week course of oral prednisone. The heparinized venous blood was collected, and peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque gradient centrifugation. The immunocytochemical assay was used to investigate the expression of two isoforms of GR in PBMC. The cytoplasm protein and nuclear protein extracts from PBMC were obtained, and the quantity of GR α and GR β proteins were analyzed by Western blotting assay. Then the GR-DNA-binding activity was detected by electrophoretic mobility shift assay (EMSA). Results The two isoforms of GR were expressed in PBMC in INS and healthy children. The percentages of GR αpositive staining cells in GC-resistance INS and GC-sensitive INS were significantly lower than that in healthy children (P0.01), but no significant difference was found between two INS groups. However, the number of GR β positive staining cells in GC-resistant INS was significantly higher than that in GC-sensitive INS (P0.01). Results of Western blots assay identified the presence of only one specific protein band at the expected molecular weight 94 000 or 90 000, which was consistent with those of GR α and GR β, respectively. In GC-resistant INS children, the quantity of GR α protein in GC-resistant INS group was significantly higher in the cytoplasm, and significantly lower in the nuclei, while the quantity of GR β protein in the nuclei was significantly higher than that of GC-sensitive INS, respectively. The results of EMSA showed that GR-DNA-binding activity in GR-resistant INS group was decreased compared to GR-sensitive INS group. Conclusions The patients with GC-resistant INS have an increased expression of GR β. The imbalanced expression between GR α and GR β, especially increased expression of GR β in PBMC might account for GC-resistant INS. GR β might antagonize GC-mediated GR α function by prohibiting the GR α translocation into the nuclei and depressing GR-DNA binding activity. This finding suggests that GR β might be a critical factor regulating the responsiveness of the target cell to GC. The ability of GR β to repress the action of GR α also illustrates a new insight to the satisfactory explanation of why some INS children respond to GC and others do not.

Effects of splicing factor SRp40 on the expression of GRα/β mRNA and on glucocorticoid therapy for nephrotic syndrome

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Expression of GRα, GRβ in Peripheral Blood Mononuclear Cells in Patients with Primary Nephrotic Syndrome and Its Clinical Significance

[Effect of Glucocorticoid on Glucocorticoid-Resistant Children with Primary Nephrotic Syndrome].

Changes and Significance of Glucocorticoid Receptor β and Heat Shock Proteins 90 in Peripheral Blood in Children with Primary Nephritic Syndrome

Research on the expressions of multiple drug-resistant gene in peripheral blood mononuclear cells of children with nephrotic syndrome

Significance of Expression of P-Glycoprotein 170 in Peripheral Blood Mononuclear Cells of Children with Primary Nephrotic Syndrome

Expressions of Multiple Drug-Resistant Gene 1 and Permeability-Glycoprotein 170 in Peripheral Blood Mononuclear Cell in Children with Primary Nephrotic Syndrome

Polymorphisms in the Glucocorticoid Receptor Gene and Associations with Glucocorticoid-Induced Avascular Osteonecrosis of the Femoral Head.

Significance of Α-and Β-Isoforms of Glucocorticoid Receptors Expression in Children with Idiopathic Nephrotic Syndrome

A Novel Method for Monitoring Glucocorticoid-Induced Changes of the Glucocorticoid Receptor in Kidney Transplant Recipients

Response of Glucocorticoid Receptor Alpha and Histone Deacetylase 2 to Glucocorticoid Treatment Predicts the Prognosis of Sudden Sensorineural Hearing Loss

The expression and clinical implications of glucocorticoid receptor α and β mRNA in peripheral blood mononuclear cells in children with infantile spasms

Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study.

Association of Glucocorticoid Receptor Expression with the Treatment Outcome of Pemetrexed-Based Chemotherapy in NSCLC Patients.

Glucocorticoid Receptor Expression and Glucocorticoid Therapeutic Effect in Nasal Polyps.

[Analysis of prognostic factors in patients with refractory sudden sensorineural hearing loss].

Effect of Tripterygium Glycosides Combined with Hormones on Adult NS Glucocorticoid Resistance and HSP90

Role of P-gp170 in steroid-resistant primary nephrotic syndrome in children

Clinical Value of ABCB1 and PAI-1 Gene Polymorphisms in Predicting Glucocorticoid-induced Adverse Reactions in Nephrotic Syndrome Patients

Change of the Nuclear Protein Level of GR, AP-1 and NF-κB During the Glucocorticoid Treatment in Idiopathic Nephrotic Syndrome